Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company in the development stage, dedicated to developing drugs for central nervous system disorders. The company's main candidate product includes TNX-102 SL, a formulation and dosage of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of several other candidate products, including TNX-201 and TNX-301, which can treat certain types of headaches.